<DOC>
	<DOC>NCT01589367</DOC>
	<brief_summary>Preoperative letrozole versus letrozole with metformin in postmenopausal Estrogen receptor positive breast cancer patients Phase II multicenter 1:1 randomized clinical trial Total 208 patients Primary endpoint Clinical response rate Secondary endpoint Pathologic complete response rate Breast conserving surgery rate Percent mammographic density change Ki67(%) change after 4week medication of 2nd core needle biopsy Toxicity profile of neoadjuvant letrozole, metformin</brief_summary>
	<brief_title>Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer</brief_title>
	<detailed_description>To identify the anti-tumor effect of metformin with preoperatively given letrozole in postmenopausal estrogen receptor positive breast cancer patients</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Estrogen receptor positive breast cancer Clinically measurable tumor size(stage II/III) No evidence of distant metastasis Postmenopause women 'Age≥60yr' OR 'previous bilateral oophorectomy' OR 'FSH&gt;30 with no bleeding history within 1yr' ECOG 02 Adequate hepatorenal, bone marrow function 'serum Cr&lt;1.4mg/dL' AND 'Bilirubin&lt; upper limit of normal x 1.5 AND 'AST/ALT &lt; upper limit of normal x 1.8 AND 'ALP &lt; upper limit of normal x 1.8 AND 'Hemoglobin &gt;10 g/dL' AND 'ANC &gt;1,500/mm3' AND 'Platelet &gt;100,000/mm3' Spontaneous signed into the written informed consent Who does not meet the above inclusion criteria History of other carcinoma Uncontrolled infection History of psychiatric, epileptic disease Male breast cancer Diabetes 'HbA1c≥6.5' OR 'FBS≥126mg/dL' Hypersensitivity or intolerance to metformin Risk of metformin associated lactic acidosis 'Congestive heart disease of NYHA Class llll/IV' OR 'History of other acidosis' OR 'Alcohol intake more than either 3 bottles beer OR 1 bottle Soju' During medication of metformin, sulfonylureas, thiazolidinediones, insulin Diffuse microcalcification in mammogram Multiple OR bilateral OR inflammatory breast cancer Chemotherapy or endocrine therapy within 2yr due to history of breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>neoadjuvant endocrine therapy</keyword>
	<keyword>metformin</keyword>
	<keyword>postmenopausal breast cancer</keyword>
</DOC>